dentons.cn | 大成证字2022第 | 181-11 | 号 | www.dentons.cn | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Tel: | +86 | 574-8732 | 6088 | Fax: | +86 | 574-8789 | 3911 | dentons.cn | | 释 | 义 | 本法律意见书中，除非另有说明，下列简称具有如下含义： | | | | | | | | 本所 | 指 | 北京大成（宁波）律师事务所 | 本法律意见书 | 指 | 《北京大成（宁波）律师事务所关于宁波德业科技 | | | | | 2022 | 股份有限公司 | 年股票期权激励计划之首次授 | 予部分第三个行权期、剩余预留授予部分第二个行 | | | | | | | 权期行权条件成就及注销部分股票期权事项的法律 | 意见书》 | | | | | | | | | 本所律师 | 指 | 北京大成（宁波）律师事务所委派的律师，即在本 | 法律意见书签署页"经办律师"一栏签名的律师 | | | | | | | 德 ...

证券代码：605117 证券简称：德业股份 公告编号：2025-064 宁波德业科技股份有限公司 关于 2022 年股票期权激励计划剩余预留授予部分 第二个行权期行权条件成就的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： ? 股票期权拟行权数量：59.5007 万份 ? 行权股票来源：向激励对象定向发行本公司 A 股普通股 宁波德业科技股份有限公司（以下简称"公司"）于 2025 年 6 月 30 日召开 第三届董事会第十六次会议、第三届监事会第十四次会议，审议通过了《关于 案》。公司 2022 年股票期权激励计划剩余预留授予的股票期权第二个行权期行权 条件已经成就，现将相关事项公告如下： 一、2022 年股票期权激励计划批准及实施情况 （一）已履行的决策程序和信息披露情况 波德业科技股份有限公司2022年股票期权激励计划（草案）及其摘要》《宁波德 业科技股份有限公司2022年股票期权激励计划实施考核管理办法》《关于提请股 东大会授权董事会办理2022年股票期权激励计划相关事宜的议案》。公司独立董 ...

证券代码：605117 证券简称：德业股份 公告编号：2025-065 宁波德业科技股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 宁波德业科技股份有限公司（以下简称"公司"）于 2025 年 6 月 30 日召开 第三届董事会第十六次会议、第三届监事会第十四次会议，审议通过了《关于注 销部分股票期权的议案》。现将相关事项公告如下： 一、已履行的决策程序和信息披露情况 波德业科技股份有限公司2022年股票期权激励计划（草案）及其摘要》《宁波德 业科技股份有限公司2022年股票期权激励计划实施考核管理办法》《关于提请股 东大会授权董事会办理2022年股票期权激励计划相关事宜的议案》。公司独立董 事对此发表了独立意见。 同日，公司召开第二届监事会第十三次会议，审议通过了《宁波德业科技股 份有限公司2022年股票期权激励计划（草案）及其摘要》《宁波德业科技股份有 限公司2022年股票期权激励计划实施考核管理办法》《关于核实 <宁波德业科技> 股份有限公司2022年股票期权激励计划激励对象名单>的议案》。公司监事会 ...

Summary of Key Points Core Viewpoint - The company has decided to cancel a portion of stock options from its 2023 stock option incentive plan due to the departure of 12 incentive recipients, which no longer meet the incentive conditions [1]. Group 1: Stock Option Cancellation - The company will cancel a total of 1,110,400 stock options that were granted but not exercised [1]. - Of these, 57,800 stock options will be canceled because the first exercise period ended on June 19, 2025, and they were not exercised [1]. - Additionally, 1,527,000 stock options will be canceled as the conditions for the second exercise period were not met [1].

Meeting Overview - The third meeting of the Supervisory Board of Jiangsu Aidi Pharmaceutical Co., Ltd. was held on June 27, 2025, with all three supervisors present, confirming the legality and validity of the meeting [1]. Resolutions Passed - The Supervisory Board approved the proposal to cancel part of the unvested restricted stock, stating that it complies with relevant laws and regulations, and does not harm shareholders' interests [1][2]. - The Supervisory Board approved the draft of the 2025 Stock Option Incentive Plan, which aligns with legal requirements and is expected to benefit the company's sustainable development [2][3]. - The Supervisory Board approved the implementation assessment management measures for the 2025 Stock Option Incentive Plan, ensuring smooth execution and alignment with the company's governance structure [3][4]. - The Supervisory Board verified the list of initial incentive objects for the 2025 Stock Option Incentive Plan, confirming their qualifications under relevant laws and regulations [4][5]. - The Supervisory Board approved changes to certain fundraising investment projects and amount adjustments, aimed at enhancing operational stability and profitability [5][6]. - The Supervisory Board agreed to nominate Tang Jieqing as a candidate for a non-employee representative supervisor, pending shareholder approval [6][7]. - The Supervisory Board elected current employee representative supervisor Pang Qiuchen as the chairman of the Supervisory Board, effective immediately [7].

Core Viewpoint - The company has announced adjustments to the exercise price of its 2024 stock option incentive plan and the cancellation of certain stock options due to individual performance assessments not being met [1][4][6]. Group 1: Stock Option Incentive Plan Adjustments - The board of directors and the supervisory board have approved the adjustment of the exercise price for the 2024 stock option incentive plan, reducing it from 8.80 yuan to 8.20 yuan per share after a cash dividend distribution of 0.60 yuan per share [4][5][6]. - A total of 0.96 million stock options will be canceled for three individuals who did not meet the performance criteria [5][6]. Group 2: Compliance and Approval - The adjustments and cancellations have been verified by the remuneration and assessment committee, and the supervisory board has confirmed that the procedures followed are in compliance with relevant regulations [6][7]. - The independent financial advisor has also confirmed that the adjustments have received the necessary approvals and comply with applicable laws and regulations [7]. Group 3: Impact on Company - The adjustments to the exercise price and the cancellation of stock options are not expected to have a significant impact on the company's financial status or operational results [5][6].

Group 1 - The core point of the legal opinion is to confirm the legality and compliance of the 2025 stock option incentive plan proposed by Guangzhou Shanshui Bide Design Co., Ltd. [2][3][25] - The company has obtained approval from the China Securities Regulatory Commission for its initial public offering and is listed on the Shenzhen Stock Exchange [4][5]. - The company has a registered capital of 90.496 million RMB and is classified as a joint-stock company [5][6]. Group 2 - The incentive plan aims to attract and retain talented employees while aligning the interests of shareholders, the company, and employees [7][24]. - A total of 79 core employees will be granted stock options, excluding directors, supervisors, and senior management [8][11]. - The plan involves granting 2.705 million stock options, accounting for 13.31% of the total share capital at the time of the announcement [9][10]. Group 3 - The exercise price for the stock options is set at 43.81 RMB per share, which is compliant with regulatory requirements [16][17]. - The plan includes performance assessments for both company-level and individual-level evaluations over the 2025-2026 fiscal years [19][18]. - The company has fulfilled necessary legal procedures for the implementation of the incentive plan, pending approval from the shareholders' meeting [20][23]. Group 4 - The plan does not involve any financial assistance to the incentive participants, ensuring compliance with relevant regulations [24][25]. - The independent directors and supervisory board have reviewed the plan and confirmed its legality and alignment with the company's sustainable development goals [21][22]. - The company is required to disclose relevant information following the approval of the plan to ensure transparency [24].

关于调整 2024 年股票期权激励计划行权价格的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、2024 年股票期权激励计划已履行的决策程序和信息披露情况 （一）历次已履行的决策程序和信息披露情况 于 2024 年 2 月 26 日召开的公司十届八次董事会审议通过了《关于 <东软集> 团股份有限公司 2024 年股票期权激励计划（草案）>及其摘要的议案》《关于< 东软集团股份有限公司 2024 年股票期权激励计划考核管理办法>的议案》以及 证券代码：600718 证券简称：东软集团 公告编号：临 2025-044 东软集团股份有限公司 于 2025 年 6 月 25 日召开的公司十届十五次监事会以通讯表决方式召开，本 次会议应到会监事 5 名，实到 5 名，会议的召开合法有效。会议审议通过了《关 《关于提请公司股东大会授权董事会办理 2024 年股票期权激励计划相关事宜的 议案》 。具体内容，详见本公司于 2024 年 2 月 28 日刊登在《中国证券报》 《上海 证券报》上的相关公告。 于 2024 年 2 月 2 ...

Core Viewpoint - The company has announced the achievement of the exercise conditions for the third exercise period of its 2022 stock option incentive plan, allowing 358 eligible participants to exercise a total of 11,679,250 stock options at an exercise price of 9.76 yuan per share, effective from July 1, 2025, to March 31, 2026 [1][2][11]. Summary by Sections Stock Option Incentive Plan - The stock option incentive plan was approved by the company's board and involves a total of 11,679,250 stock options, representing 1.3991% of the company's total share capital [1][2]. - The exercise price for the first grant of stock options was set at 9.76 yuan per share, following adjustments due to annual profit distributions [5][12]. Approval Process - The board of directors has completed all necessary approval procedures for the stock option incentive plan, including independent opinions from independent directors [2][3]. - The plan has undergone multiple reviews and adjustments, including changes to the list of incentive recipients and the number of options granted [3][4]. Performance Assessment - The performance assessment for the incentive plan spans from 2022 to 2025, with specific annual targets for net profit and revenue [8][9]. - The exercise conditions are based on the achievement of these performance targets, with a detailed breakdown of the required metrics for each exercise period [8][10]. Impact on Financials - If all options are exercised, the company's total share capital will increase from 834,797,184 shares to 846,476,434 shares, which may dilute earnings per share and return on equity [14][15]. - The company will manage the funds raised from the exercise of options in a dedicated account to supplement its working capital [15]. Tax and Compliance - Participants are responsible for their personal income tax, which will be withheld and paid by the company [15]. - The company will disclose any changes in the list of incentive recipients and significant adjustments to stock option parameters in its regular reports [15][16].

Core Viewpoint - The company is holding its third extraordinary general meeting of shareholders in 2025 to discuss and approve the stock option incentive plan aimed at attracting and retaining talent while aligning the interests of shareholders, the company, and key personnel [4][5]. Group 1: Meeting Procedures - The meeting is scheduled for July 2, 2025, at 14:30 in Shenzhen, with a combination of on-site and online voting methods [3]. - Shareholders must sign in 30 minutes before the meeting and present necessary identification documents [2]. - The meeting will follow a structured agenda, including the reading of meeting guidelines, selection of representatives for vote counting, and discussion of key proposals [3][4]. Group 2: Proposals for Discussion - Proposal 1: The company has developed a draft for the 2025 stock option incentive plan to establish a long-term incentive mechanism for attracting and retaining talent [4]. - Proposal 2: A management method for the implementation and assessment of the stock option incentive plan has been created to ensure its smooth execution [5]. - Proposal 3: The board seeks authorization from shareholders to manage various aspects of the stock option incentive plan, including determining grant dates and adjusting option quantities in response to corporate actions [7][8]. Group 3: Rights and Conduct - Attendees have the right to speak, inquire, and vote, but must obtain permission from the meeting host for questions unrelated to the agenda [2]. - The meeting prohibits recording, photography, or any disruptive behavior, with staff authorized to intervene if necessary [2].